Review: taking Pseudoephedrine hydrochloride and Levothyroxine thyroid together


Summary

Drug interactions are reported among people who take Pseudoephedrine hydrochloride and Levothyroxine thyroid together. This review analyzes the effectiveness and drug interactions between Pseudoephedrine hydrochloride and Levothyroxine thyroid. It is created by eHealthMe based on reports of 337 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Pseudoephedrine hydrochloride and Levothyroxine thyroid >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Pseudoephedrine Hydrochloride

Pseudoephedrine hydrochloride has active ingredients of pseudoephedrine hydrochloride. It is often used in bronchitis. (latest outcomes from Pseudoephedrine hydrochloride 3 users)

Levothyroxine Thyroid

Levothyroxine thyroid has active ingredients of levothyroxine sodium. It is often used in hypothyroidism. (latest outcomes from Levothyroxine thyroid 730 users)

On Jul, 27, 2016

337 people who take Pseudoephedrine Hydrochloride, Levothyroxine Thyroid are studied.


Number of reports submitted per year:

Pseudoephedrine hydrochloride and Levothyroxine thyroid drug interactions.

Drug effectiveness over time:

Pseudoephedrine Hydrochloride:
  • < 1 month: 11.0% - (1 of 9 people)
  • 1 - 6 months: 0.0% - (0 of 2 people)
  • 6 - 12 months: 0.0% - (0 of 4 people)
  • 1 - 2 years: 25.0% - (1 of 4 people)
  • 2 - 5 years: 40.0% - (2 of 5 people)
  • 5 - 10 years: 100.0% - (1 of 1 people)
  • 10+ years: 100.0% - (4 of 4 people)
  • not specified: 100.0% - (1 of 1 people)
Levothyroxine Thyroid:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 100.0% - (1 of 1 people)
  • 6 - 12 months: 33.0% - (1 of 3 people)
  • 1 - 2 years: 60.0% - (3 of 5 people)
  • 2 - 5 years: 25.0% - (1 of 4 people)
  • 5 - 10 years: 55.0% - (5 of 9 people)
  • 10+ years: 100.0% - (11 of 11 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Pseudoephedrine Hydrochloride:
  • female: 37.0% - (10 of 27 people)
  • male: 0.0% - (0 of 3 people)
Levothyroxine Thyroid:
  • female: 63.0% - (19 of 30 people)
  • male: 75.0% - (3 of 4 people)

Drug effectiveness by age:

Pseudoephedrine Hydrochloride:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 1 people)
  • 20-29: 0.0% - (0 of 1 people)
  • 30-39: 11.0% - (1 of 9 people)
  • 40-49: 37.0% - (3 of 8 people)
  • 50-59: 42.0% - (3 of 7 people)
  • 60+: 75.0% - (3 of 4 people)
Levothyroxine Thyroid:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 1 people)
  • 20-29: 75.0% - (3 of 4 people)
  • 30-39: 60.0% - (6 of 10 people)
  • 40-49: 50.0% - (4 of 8 people)
  • 50-59: 71.0% - (5 of 7 people)
  • 60+: 100.0% - (4 of 4 people)

Most common drug interactions over time *:

< 1 month:
  • blood pressure increased
  • haemorrhagic stroke
  • vasospasm
  • agitation
  • amnesia
  • cerebral artery occlusion
  • confusional state
  • physical assault
  • speech disorder
  • anxiety
1 - 6 months:
  • headache
  • sinus congestion
  • complications of maternal exposure to therapeutic drugs
  • gastroschisis
  • maternal drugs affecting foetus
6 - 12 months:
  • agitation
  • amnesia
  • confusional state
  • physical assault
  • speech disorder
  • anxiety
  • hair loss
  • heart palpitations
  • heart rate increased
  • renal failure
1 - 2 years:
  • dark circles under eyes
  • hypothyroidism
2 - 5 years:
  • insomnia
  • palpitations
  • dark circles under eyes
5 - 10 years:
  • arrhythmia
  • arteriosclerosis
  • atelectasis
  • autonomic nervous system imbalance
  • chronic fatigue syndrome
  • cognitive disorder
  • colonic polyp
  • dental caries
  • diverticulum
  • dyspepsia
10+ years:
  • itching - vaginal area
  • pain of skin
  • vulvovaginal burning sensation
  • back pain
  • cerebrovascular accident
  • palpitations
  • transient ischaemic attack
  • cough
  • exhaustion, fatigue, lethargy, tiredness, weariness
  • hair loss
not specified:
  • anxiety
  • pain
  • nausea
  • insomnia
  • injury
  • osteoarthritis
  • fall
  • abscess
  • sinusitis
  • oedema peripheral

Most common drug interactions by gender *:

female:
  • anxiety
  • pain
  • nausea
  • injury
  • osteoarthritis
  • fall
  • abscess
  • insomnia
  • oedema peripheral
  • sinusitis
male:
  • thyroid neoplasm
  • drug exposure during pregnancy
  • insomnia
  • right ventricular hypertrophy
  • apnoea
  • atrial septal defect
  • bacterial sepsis
  • bronchomalacia
  • exomphalos
  • feeling hot

Most common drug interactions by age *:

0-1:
  • apgar score low
  • congenital anomaly
  • congenital cerebrovascular anomaly
  • haemorrhage intracranial
  • hydrocephalus
  • maternal drugs affecting foetus
  • neonatal disorder
  • nervous system disorder
10-19:
  • asthma aggravated
  • drug ineffective
20-29:
  • anxiety
  • biliary dyskinesia
  • bulimia nervosa
  • decreased appetite
  • deep vein thrombosis
  • gallbladder disorder
  • injury
  • pain
  • umbilical cord around neck
  • arthralgia
30-39:
  • anxiety
  • palpitations
  • insomnia
  • dizziness
  • agitation
  • amnesia
  • blood thyroid stimulating hormone increased
  • feeling abnormal
  • feeling hot
  • multiple sclerosis relapse
40-49:
  • pain
  • pulmonary embolism
  • pyrexia
  • dysphonia
  • abscess
  • anaemia
  • bone disorder
  • deafness
  • dental caries
  • facial pain
50-59:
  • insomnia
  • oedema peripheral
  • chest pain
  • anxiety
  • eye discharge
  • fall
  • pain
  • sinusitis
  • nausea
  • abscess
60+:
  • anxiety
  • osteoarthritis
  • osteomyelitis
  • pneumonia
  • nausea
  • cellulitis
  • nervousness
  • aphasia
  • cardiac failure congestive
  • dyspnoea

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Pseudoephedrine hydrochloride and Levothyroxine thyroid?

Can you answer these questions?

More questions for: Pseudoephedrine hydrochloride, Levothyroxine thyroid

You may be interested in these reviews

More reviews for: Pseudoephedrine hydrochloride, Levothyroxine thyroid

On eHealthMe, Pseudoephedrine hydrochloride (pseudoephedrine hydrochloride) is often used to treat bronchitis. Levothyroxine thyroid (levothyroxine sodium) is often used to treat hypothyroidism. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.